-
公开(公告)号:US3531471A
公开(公告)日:1970-09-29
申请号:US3531471D
申请日:1966-03-10
申请人: HOECHST AG
IPC分类号: C07C233/00 , C07D207/26 , C07D227/08 , C07D41/06
CPC分类号: C07D207/26 , C07C233/00 , C07D227/08
-
公开(公告)号:US20160046613A1
公开(公告)日:2016-02-18
申请号:US14776603
申请日:2014-03-10
发明人: Brian W. METCALF , Zhe LI , Qing XU , Stephen L. GWALTNEY, II , Jason R. HARRIS , Calvin W. YEE
IPC分类号: C07D405/14 , C07D211/70 , C07D213/69 , C07D405/04 , C07D401/04 , C07D401/14
CPC分类号: C07D401/04 , A61K8/4913 , A61K31/445 , A61K31/5375 , C07D211/70 , C07D213/30 , C07D213/69 , C07D227/08 , C07D257/04 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/14 , C07D471/04
摘要: Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
-
3.
公开(公告)号:US08541600B2
公开(公告)日:2013-09-24
申请号:US13183275
申请日:2011-07-14
申请人: James M. Frincke
发明人: James M. Frincke
IPC分类号: C07D221/18 , C07D227/08
CPC分类号: C07D221/18 , A61K31/352 , A61K31/382 , A61K31/56 , C07D227/08 , C07J73/003 , C07J73/005 , C07J73/006
摘要: The invention provides compositions comprising formula 1 steroids, e.g., 16α-bromo-3β-hydroxy-5α-androstan-17-one hemihydrate and one or more excipients, including compositions that comprise a liquid formulation comprising less than about 3% v/v water. The compositions are useful to make improved pharmaceutical formulations. The invention also provides methods of intermittent dosing of steroid compounds such as analogs of 16α-bromo-3β-hydroxy-5α-androstan-17-one and compositions useful in such dosing regimens. The invention further provides compositions and methods to inhibit pathogen replication, ameliorate symptoms associated with immune dysregulation and to modulate immune responses in a subject using the compounds. The invention also provides methods to make and use these immunomodulatory compositions and formulations.
摘要翻译: 本发明提供包含式1类固醇的组合物,例如16α-溴-3β-羟基-5α-雄甾烷-17-酮半水合物和一种或多种赋形剂,包括包含低于约3%v / v水的液体制剂的组合物 。 该组合物可用于制备改进的药物制剂。 本发明还提供了类固醇化合物如16α-溴-3β-羟基-5α-雄甾烷-17-型的类似物的间歇给药方法和用于该给药方案的组合物。 本发明进一步提供抑制病原体复制,改善与免疫调节异常有关的症状并使用该化合物调节受试者的免疫应答的组合物和方法。 本发明还提供了制备和使用这些免疫调节组合物和制剂的方法。
-
公开(公告)号:US4692521A
公开(公告)日:1987-09-08
申请号:US808558
申请日:1985-12-13
IPC分类号: C07D207/263 , C07D211/76 , C07D223/08 , C07D223/10 , C07D225/02 , C07D227/08 , C07D227/087 , C08G18/10 , C08G63/685 , C08G63/91 , C08G65/32 , C08G69/00 , C08G69/14 , C08G69/18 , C08G69/20 , C08G69/40 , C08G69/42 , C08G69/44 , C08G77/32 , C08G77/388 , C08G85/00
CPC分类号: C08G69/44 , C07D227/08 , C08G18/10 , C08G69/14 , C08G69/18 , C08G69/20 , C08G69/40 , C08G69/42 , C08G2120/00
摘要: The invention relates to N-substitutecd acyl lactam compounds of the formula ##STR1## where R is a polyol residue originating from a polyol with the formula R-(OH).sub.x where x is a number.ltoreq.2R' a bivalent cyclic or non-cyclic alkyl, aralkyl, alkaryl or aryl radicalR" a bivalent radical having the following general formula ##STR2## wherein R'" is H, alkyl, cycloalkyl, aryl, alkaryl or aralkyl,R.sup.iv is H, alkyl, cycloalkyl, aryl, alkaryl or aralkyl whereR"' and R.sup.iv may jointly form a substituted or non-substituted cycloalkyl residuen is 0 or 1 and(-L) represents a non-opened lactam ring of the formula ##STR3## wherein Y is hydrocarbon residue with 3-11 carbon atoms. It has been found that this group of compounds is very suitable as activator in the preparation of nylon block copolymers, more specifically in the RIM or RRIM systems.
摘要翻译: 本发明涉及式(IMAGE)的N-取代的酰基内酰胺化合物,其中R是衍生自具有式R-(OH)x的多元醇的多元醇残基,其中x是二价环状的数字, 非环烷基,芳烷基,烷芳基或芳基R“具有以下通式的二价基团,其中R”'是H,烷基,环烷基,芳基,烷芳基或芳烷基,Riv是H,烷基,环烷基 ,芳基,烷芳基或芳烷基,其中R“'和Riv可以共同形成取代或未取代的环烷基残基n为0或1,(-L)表示式”IMAGE“的未开封的内酰胺环,其中Y为 具有3-11个碳原子的烃残基。 已经发现,这组化合物在制备尼龙嵌段共聚物中非常适合作为活化剂,更具体地说在RIM或RRIM系统中。
-
5.
公开(公告)号:US3541211A
公开(公告)日:1970-11-17
申请号:US3541211D
申请日:1968-05-08
申请人: GEIGY CHEM CORP
发明人: GATZI KARL
IPC分类号: C07D207/26 , C07D211/76 , C07D223/12 , C07D227/08 , A01N9/00
CPC分类号: C07D207/26 , C07D211/76 , C07D223/12 , C07D227/08
-
公开(公告)号:US20230322704A1
公开(公告)日:2023-10-12
申请号:US17981140
申请日:2022-11-04
发明人: Brian W. Metcalf , Zhe Li , Qing Xu , Stephen L. Gwaltney, II , Jason R. Harris , Calvin W. Yee
IPC分类号: C07D401/04 , C07D401/14 , C07D405/14 , C07D401/12 , C07D471/04 , C07D257/04 , C07D213/30 , C07D487/04 , C07D231/56 , C07D211/62 , C07D213/64 , C07C65/30 , C07F7/08 , A61K8/49 , A61K31/445 , A61K31/5375 , C07D211/70 , C07D213/69 , C07D227/08 , C07D405/04
CPC分类号: C07D401/04 , C07D401/14 , C07D405/14 , C07D401/12 , C07D471/04 , C07D257/04 , C07D213/30 , C07D487/04 , C07D231/56 , C07D211/62 , C07D213/64 , C07C65/30 , C07F7/0812 , A61K8/4913 , A61K31/445 , A61K31/5375 , C07D211/70 , C07D213/69 , C07D227/08 , C07D405/04
摘要: Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
-
公开(公告)号:US10017491B2
公开(公告)日:2018-07-10
申请号:US15445878
申请日:2017-02-28
发明人: Brian W. Metcalf , Chihyuan Chuang
IPC分类号: C07D401/04
CPC分类号: C07D401/04 , A61K8/4913 , A61K31/445 , A61K31/5375 , C07D211/70 , C07D213/30 , C07D213/69 , C07D227/08 , C07D257/04 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/14 , C07D471/04
摘要: Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
-
公开(公告)号:US20170174654A1
公开(公告)日:2017-06-22
申请号:US15445878
申请日:2017-02-28
发明人: Brian W. METCALF , Chihyuan Chuang
IPC分类号: C07D401/04
CPC分类号: C07D401/04 , A61K8/4913 , A61K31/445 , A61K31/5375 , C07D211/70 , C07D213/30 , C07D213/69 , C07D227/08 , C07D257/04 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/14 , C07D471/04
摘要: Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
-
公开(公告)号:US20140275152A1
公开(公告)日:2014-09-18
申请号:US13815770
申请日:2013-03-15
发明人: Brian W. Metcalf , Zhe Li
IPC分类号: C07D471/04 , C07D401/12 , C07D257/04 , C07D227/08 , C07D213/30 , C07D401/04
CPC分类号: C07D401/04 , A61K8/4913 , A61K31/445 , A61K31/5375 , C07D211/70 , C07D213/30 , C07D213/69 , C07D227/08 , C07D257/04 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/14 , C07D471/04
摘要: Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
-
公开(公告)号:US4499273A
公开(公告)日:1985-02-12
申请号:US451882
申请日:1982-12-21
IPC分类号: C08L7/00 , C07D211/44 , C07D227/08 , C08K5/34 , C08K5/3432 , C08K5/3435 , C08L21/00 , C08L23/00 , C08L67/00 , C08L101/00
CPC分类号: C07D227/08 , C07D211/44 , C08K5/3435
摘要: There are disclosed new organic peroxides having two peroxy functional groups and containing in their molecule an atom of salified aminic nitrogen, having the general formula: ##STR1## in which: R.sub.1, R.sub.2 are each an alkyl radical having 1 to 8 carbon atoms, optionally aryl-substituted, preferably a tertiary alkyl group such as t.butyl, t.amyl, t.octyl and cumyl;R.sub.3 is a hydrogen, an alkyl radical having 1 to 8 carbon atoms, a cycloalkyl having 5-6 carbon atoms in the ring, an aryl, an arylalkyl optionally halogen, alkoxy-, carboalkoxy-, alkyl-, mono- or poly-substituted;R.sub.4 is the methylene, ethylene or trimethylene radical, optionally halogen-, alkoxy-, carboalkoxy-, aryl-, alkyl-, mono- or poly-substituted;R.sub.5 is the methylene or ethylene radical optionally halogen-, alkoxy-, carboalkoxy-, alkyl-, aryl-, mono- or poly-substituted;X is an anion or an inorganic or organic acid in which one or more acid hydrogens are substituted by the aminic cation;n is 1, 2 or 3 and represents the number of hydrogen atoms which are salified.The peroxides so salified are employed in the crosslinking of plastomers, natural and synthetic elastomers and thermosetting resins.This invention relates to salts of amino organic peroxides and, more particularly, to new organic peroxides having the peroxy functional groups, containing in their molecule an atom of salified aminic nitrogen, as well as to the use thereof in the cross-linking of plastomers, natural and synthetic elastomers and thermosetting resins.
摘要翻译: 公开了具有两个过氧官能团的新的有机过氧化物,并且在其分子中含有盐化的氨基氮原子,具有以下通式:其中:R 1,R 2各自为具有1至8个碳原子的烷基,任选地 芳基取代的,优选叔烷基如叔丁基,叔戊基,辛基和枯基; R3是氢,具有1至8个碳原子的烷基,环中具有5-6个碳原子的环烷基,芳基,任选卤素的芳烷基,烷氧基 - ,烷氧基 - ,烷基 - ,单 - 或多取代 ; R4是亚甲基,亚乙基或三亚甲基,任选是卤素,烷氧基,烷氧基,芳基,烷基,单或多取代的; R5是任选卤素,烷氧基,烷氧基,烷基,芳基,单取代或多取代的亚甲基或亚乙基; X是其中一个或多个酸氢被氨基阳离子取代的阴离子或无机或有机酸; n为1,2或3,表示成盐的氢原子数。 如此成盐的过氧化物用于塑性体,天然和合成弹性体和热固性树脂的交联。 本发明涉及氨基有机过氧化物的盐,更具体地说,涉及具有过氧官能团的新型有机过氧化物,其分子中含有盐化氨基氮的原子,以及其在塑性体交联中的用途, 天然和合成弹性体和热固性树脂。
-
-
-
-
-
-
-
-
-